Xencor reported $2.01B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Arrowhead Research ARWR:US $ 8.62B 1.74B
AstraZeneca AZN:LN 113.99B 18.86B
Biogen BIIB:US $ 52.13B 9.52B
Bristol Myers Squibb BMY:US $ 148.48B 7.52B
Cytokinetics CYTK:US $ 1.42B 244.24M
Epizyme EPZM:US $ 847.42M 40.73M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Johnson & Johnson JNJ:US $ 433825.66M 1140.33M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Macrogenics MGNX:US $ 1.62B 176.65M
Merk MRK:US $ 196918.18M 1780.24M
Novartis NOVN:VX 208.02B 8.76B
Pfizer PFE:US $ 219205.69M 17108.81M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Seattle Genetics SGEN:US $ 28.65B 3.48B
Xencor XNCR:US $ 2.01B 489.02M